Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

DJM PAN Unlimited unveils in-house digital technology centre

Skunkworks will allow clients a ‘hands-on’ experience of digital innovation

- PMLiVE

The AMR threat

The scale of the antimicrobial resistance challenge

- PMLiVE

UK government fines GSK over ‘pay-for-delay’ deals

Merck KGaA and Actavis also fined for their involvement

- PMLiVE

Incyte abandons solid tumour programme for Jakafi

Drug discontinued after failure to show efficacy in trials

ABPI appoints Mike Thompson as chief executive

He replaces acting chief executive officer Alison Clough

- PMLiVE

Pharma could make more of its real world evidence

As the ‘cost versus value’ argument rears its head once again a new award could help pharma reaffirm the value of its medicines

- PMLiVE

Change and what’s new

Is anything really that different?

- PMLiVE

Gregory Gallo joins Treato as chief commercial officer

Brings experience from Quest Diagnostics and Johnson & Johnson

EU flag

Sandoz files for approval of Neulasta biosimilar in Europe

Amgen facing increasing competition in global biosimilar market

- PMLiVE

People not positions

The race is on to find - and nurture - the very best talent

- PMLiVE

Mylan agrees to buy Sweden’s Meda for $7.2bn

Deal is set to boost its over-the-counter medicines portfolio 

- PMLiVE

It’s time to get with the real world

Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links